• 16 November 2017

    Support for the use of Inflectra in Crohn’s disease

    A recent report shows patients suffering from Crohn’s disease (CD) who changed their treatment from Remicade to Inflectra experienced comparable efficacy, safety and tolerability to treatment over a six-month period.

  • 15 November 2017

    ICER and NICE: are they that different?

    The Institute for Clinical and Economic Review (ICER) is a non-profit organization in the US that aims to evaluate evidence of the value of medical tests, treatments and delivery system...

  • 15 November 2017

    Juno Therapeutics Explores CAR-T Trial Deaths

    At the Society for Immunotherapy for Cancer (SITC) meeting in National Harbor, Maryland this weekend, Juno Therapeutics presented findings from their investigation into the circumstances surrounding the patient deaths linked...

  • 9 November 2017

    Cystic fibrosis: matching medicines with mutations

    The 2017 North American Cystic Fibrosis Conference (NACFC) was held at the Indiana Convention Center in Indianapolis, Indiana from November 2–4. The conference annually brings together scientists, clinicians, and caregivers...